Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib
Author:
Funder
Thailand Research Fund
Prince of Songkla University
National Research Council of Thailand
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference50 articles.
1. Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database;Plasilova;Medicine (Baltim).,2016
2. Platinum-based therapy for triple-negative breast cancer treatment: a meta-analysis;Tian;Mol. Clin. Oncol.,2015
3. Membrane transporters as mediators of cisplatin side-effects;Ciarimboli;Anticancer Res.,2014
4. Binding of organometallic ruthenium(II) and osmium(II) complexes to an oligonucleotide: A combined mass spectrometric and theoretical study;Dorcier;Organometallics,2015
5. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes;Scolaro;J. Med. Chem.,2005
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal–Drug Synergism in Metallodrug Design;Molecular Pharmaceutics;2023-02-20
2. Fine-tuning the cytotoxicity of ruthenium(ii) arene compounds to enhance selectivity against breast cancers;Dalton Transactions;2023
3. Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer;Journal of Drug Delivery Science and Technology;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3